KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Novavax (NVAX) Short-Term Debt issuances: 2009-2016

Historic Short-Term Debt issuances for Novavax (NVAX) over the last 8 years, with Dec 2016 value amounting to -$45,000.

  • Novavax's Short-Term Debt issuances rose 68.31% to -$45,000 in Q4 2016 from the same period last year, while for Dec 2016 it was -$395,000, marking a year-over-year increase of 34.17%. This contributed to the annual value of -$395,000 for FY2016, which is 34.17% up from last year.
  • Per Novavax's latest filing, its Short-Term Debt issuances stood at -$45,000 for Q4 2016, which was up 56.73% from -$104,000 recorded in Q3 2016.
  • In the past 5 years, Novavax's Short-Term Debt issuances ranged from a high of -$7,000 in Q2 2012 and a low of -$170,000 during Q2 2014.
  • Moreover, its 3-year median value for Short-Term Debt issuances was -$147,000 (2015), whereas its average is -$138,833.
  • As far as peak fluctuations go, Novavax's Short-Term Debt issuances crashed by 1,285.71% in 2013, and later soared by 68.31% in 2016.
  • Over the past 5 years, Novavax's Short-Term Debt issuances (Quarterly) stood at -$40,000 in 2012, then tumbled by 320.00% to -$168,000 in 2013, then rose by 1.19% to -$166,000 in 2014, then increased by 14.46% to -$142,000 in 2015, then skyrocketed by 68.31% to -$45,000 in 2016.
  • Its Short-Term Debt issuances stands at -$45,000 for Q4 2016, versus -$104,000 for Q3 2016 and -$103,000 for Q2 2016.